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Abstract
Objective—To examine the associations between dietary fat intake and ischemic stroke among
postmenopausal women.
Methods—We conducted a prospective cohort study of 87,025 generally healthy postmenopausal
women (age 50–79 years) enrolled in the Women’s Health Initiative Observational Study.
Repeated and validated dietary assessments were done using a self-administered food frequency
questionnaire. We used Cox proportional hazards models to estimate hazard ratios (HR) of
ischemic stroke based on quintiles of the cumulative average of fat intake.
Results—We documented 1,049 incident cases of ischemic stroke over 663,041 person-years of
follow-up. Women in the highest quintile of trans fat intake had a significantly higher incidence of
ischemic stroke (HR 1.39, 95% confidence interval [CI] 1.08–1.79, P-trend = 0.048) compared
with women in the lowest quintile, while controlling for multiple covariates. The observed
association was modified by aspirin use (P-interaction=0.02). The HR was 1.66 (95% CI 1.21–
2.36, P-trend<0.01) among baseline non-aspirin users (n=67,288) and 0.95 (95% CI 0.60–1.48, P-
trend=0.43) among aspirin users (n=19,736). No significant associations were found between
intakes of saturated, monounsaturated, or polyunsaturated fat and ischemic stroke or any ischemic
stroke subtypes.
Interpretation—In this large cohort of postmenopausal women, higher intake of trans fat was
associated with incident ischemic stroke independent of major lifestyle/dietary factors. Aspirin use
may attenuate the potential adverse effect of trans fat intake on ischemic stroke.
INTRODUCTION
Trans fat intake is thought to increase incidence of cardiovascular disease through its
adverse effect on serum cholesterol, inflammation and endothelial function.1 Despite this
evidence, two large prospective cohort studies of ischemic stroke among healthcare
professionals did not find evidence of a positive association.2, 3 The associations between
other dietary fats and ischemic stroke are also inconsistent with those of coronary heart
disease (CHD) even though it is generally thought that both ischemic stroke and CHD are
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atherosclerotic disorders.4 Contrary to expectation, epidemiologic studies have suggested
that intake of saturated and animal fat intake may be inversely associated with ischemic
stroke.5, 6 Data on monounsaturated and polyunsaturated fats and ischemic stroke are sparse.
Previous studies of dietary fat and ischemic stroke have included less than 500 cases of
ischemic stroke, limiting statistical power.4 Exploring the interactions between dietary fat
intake and aspirin use and other variables that reduce risk of ischemic stroke through their
antiplatelet, cholesterol-lowering, or anti-inflammatory properties may shed light on the
mechanism of ischemic stroke development, especially since there is evidence of sex
differences in platelet reactivity and platelet response to aspirin.7 Finally, there have been no
large-scale longitudinal studies of the association between types of fat intake and ischemic
stroke among postmenopausal women who have elevated risk of stroke.
We analyzed data from the Women’s Health Initiative Observational Study (WHI-OS), a
large cohort of postmenopausal US women, to prospectively examine intakes of total and
specific types of fat in relation to incidence of ischemic stroke. We also examined the
possible effect modification of aspirin use since both fatty acids and aspirin may influence
risk of ischemic stroke through inflammatory and platelet aggregation mechanisms.
METHODS
Study Population
Full details of the WHI-OS are available at <http://whiscience.org/about/>. Between 1994
and 1998, the WHI-OS recruited women age 50 to 79 years from areas surrounding 40
clinical centers in 24 states and the District of Columbia and enrolled 93,676 women. We
excluded women who reported having had a stroke (n=1,415), transient ischemic attack
(n=2,250), or reported implausible daily energy intake (<600 or >5,000 kcal/d, n=3,571) at
baseline, leaving 87,025 women in this analysis. All participants provided written informed
consent approved by the Institutional Review Board of each participating center.
Dietary assessment
The WHI used a self-administered food frequency questionnaire (FFQ) to assess diet at
enrollment and at a follow-up visit 3 years later.8 The FFQ asked about usual frequency of
intake and portion size for 122 foods and food groups over the previous 3-month period,
including questions about fats in meat and dairy, fats used in cooking, added fats, and
reduced-fat foods. The nutrient database was derived from the University of Minnesota
Nutrition Coding Center nutrient database (2005 version, Nutrition Coordinating Center,
Minneapolis, MN).
The measurement properties of the WHI FFQ were evaluated in a sub-cohort of the WHI
and were found to be similar to other FFQs in studies of older women.8 The Pearson
correlation coefficient between the FFQ and 8 days of dietary recalls and food records were
0.64 for total fat, 0.63 for saturated fat, 0.64 for monounsaturated fat, and 0.54 for
polyunsaturated fat. The correlation coefficient for trans fat was not reported in the
evaluation study. However, in the WHI Dietary Modification Clinical Trial, a trend was
observed toward CHD reduction among the intervention group who reached the lowest
levels of trans fat and saturated fat intakes, as measured by the WHI FFQ.9 These results
coupled with the validation study demonstrate that the WHI FFQ dietary trans fat intake
assessment is appropriate and can successfully predict health endpoints including ischemic
stroke by ranking participants according to intake.
Yaemsiri et al. Page 2










Ascertainment of ischemic stroke outcome
Incident ischemic strokes during the follow-up period were identified through self-report
during annual medical history updates through 2005. The annual response rate was 94%.10
The potential outcomes were adjudicated locally by physicians and centrally by trained
neurologists using additional details from medical charts, brain imaging, or death
certificates. Over 95% of WHI-OS stroke cases were classified based on brain imaging.11
Central adjudicators further classified ischemic strokes by subtypes according to the Trial of
ORG 10172 Acute Stroke Trial (TOAST) Classification, based on the presumed underlying
stroke etiology.12 Transient ischemic attack, hemorrhagic stroke, stroke not centrally
adjudicated, strokes not requiring hospitalization, and strokes not confirmed by central
adjudication were not included as a stroke outcome.
Measurement of covariates
Participants completed physical measurements, a medication/supplement inventory, and
questionnaires during baseline visits to a WHI Clinical Center. Blood pressure was
measured by certified staff using standardized procedures after a 5-minute seated rest. The
average of two blood pressure measurements taken with a 30-second rest in between was
used in analysis. Height and weight were measured without shoes or heavy clothing and
pocket contents removed. Body mass index (BMI) was calculated by dividing weight in
kilograms by the square of height in meters. Participants who reported taking
antihypertensive or diuretic medications were classified as antihypertensive medication
users. Those who reported having high cholesterol requiring pills or taking
antihyperlipidemic medication were classified as cholesterol-lowering medication users.
Participants taking medications that contained aspirin as an ingredient for at least 14 days
were classified as aspirin users. History of CHD was defined as having self-reported a
myocardial infarction, coronary artery bypass graft, or percutaneous coronary intervention at
baseline. Physical activity was assessed using information about the frequency, intensity,
and duration of walking, exercise, or recreational activity and summarized into total
metabolic equivalent task (MET)-hours per week.
Statistical Methods
Statistical analyses were performed using SAS software, version 9.1 (SAS Institute Inc,
Cary, NC). Follow-up time was calculated in months from the date of enrollment to the date
of first stroke, death, or end of the follow up, whichever came first. According to the WHI
protocol, women were censored at the time of their first stroke, even if the stroke was non-
ischemic.
We calculated the cumulative average of intakes for total and types of fat for each
participant. If the participant was followed for the outcome past her dietary update 3 years
after baseline, then we used the average of the baseline and dietary update information.
Otherwise, we used the baseline dietary information only. Participants were divided into
quintiles based on the cumulative average of intakes of total fat or types of fat. For
descriptive statistical analysis, we examined the distribution of important covariates
according to quintiles of trans fat intake, the dietary fat which has been shown to have a
potent effect on increasing risk of cardiovascular disease.1
We used Cox proportional hazard models to estimate the hazard ratios (HR) and 95%
confidence intervals (CI) of incident ischemic stroke for each quintile of fat intake. Because
dietary fat intake and total energy intake are often highly correlated, we adjusted
multivariable models using the residual regression method to obtain a measure of nutrient
intake uncorrelated with total energy intake.13 Tests for trend were performed by assigning
the median value of each quintile of dietary fat intake to each category and entering this
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variable into the model as a continuous variable. In addition, we tested for effect
modification by including a multiplicative interaction term between quintiles of dietary fat
intake and the modifying variable.
RESULTS
This analysis included 87,025 postmenopausal women (mean age 63.5y, standard deviation
7.3y) who had no history of stroke or TIA at baseline with an average 7.6 years of follow-
up. Low socioeconomic status was associated with greater trans fat intake (Table 1). Women
in the highest quintile of trans fat intake were more likely to be current smokers, have
diabetes, and physically inactive, compared to those in the lower quintiles of trans fat intake.
Total energy intake was higher and vitamin E intake was lower in women in the higher
quintiles of trans fat intake.
Over a follow-up of 663,041 person-years, 1,049 incident cases of ischemic stroke were
documented. With minimal adjustment, there was a positive relation between trans fat intake
and incidence of ischemic stroke (Table 2, fifth vs. the first quintile HR 1.49, 95% CI 1.22–
1.82, P for trend = 0.0002). The association became slightly attenuated after adjustment for
clinical, lifestyle, and dietary factors, but remained significant. Women in the highest
quintile of trans fat intake had a 39% greater incidence of ischemic stroke than women in the
lowest quintile of trans fat intake (HR 1.39, 95% CI 1.08–1.79, P for trend = 0.048). We
evaluated trans isomers of palmitolaidic acid (16:1), elaidic acid (18:1), and linolaidic acid
(18:2) in separate models. All three were positively associated with incidence of ischemic
stroke (P for trend = 0.04, 0.09, and 0.06, respectively). No significant associations were
evident for total fat, other types of fat, dietary cholesterol, or Keys score.
In stratified analysis, there was a 66% higher incidence of ischemic stroke for women in the
highest vs. the lowest quintile of trans fat intake among non-aspirin users (n=67,288, HR
1.66, 95% CI 1.21–2.36, P for trend <0.01, Fig 1). Among aspirin users (n=19,736, 22.7%,
median dose 200 mg, interquartile range 25–500 mg), the positive associations between
trans fat and ischemic stroke were substantially attenuated (HR 0.95, 95% CI 0.60–1.48, P
for trend = 0.43). The test for interaction was statistically significant (P for interaction =
0.02). These results were consistent for all three trans isomers: P for interaction = 0.04 for
16:1, 0.002 for 18:1, and 0.003 for 18:2. There was no evidence of interaction between trans
fat intake and statin use, alcohol intake, or hormone replacement therapy use (P for
interaction = 0.85, 0.60, and 0.26, respectively).
The positive association between trans fat intake and ischemic stroke persisted using only
baseline diet, rather than cumulative diet (highest vs. lowest quintile HR 1.28, 95% CI
1.004–1.63, P for trend = 0.14). It was robust against additional exclusions for history of
CHD (highest vs. lowest quintile HR 1.42, 95% CI 1.10–1.84, P for trend = 0.04), for atrial
fibrillation (HR 1.42, 95% CI 1.09–1.86, P for trend = 0.03), and for diabetes (HR 1.47, 95%
CI 1.12–1.92, P for trend = 0.03). Therefore, we included individuals with these
comorbidities and adjusted for them in above multivariable models. To investigate the
possibility that participants changed their diet as they developed some diseases or health
conditions, we stopped updating an individual’s dietary information if they reported a
diagnosis of diabetes mellitus, myocardial infarction, revascularization, peripheral arterial
disease, or carotid artery disease. The association was slightly attenuated, but remained
significant (HR 1.37, 95% CI 1.07, 1.76, P for trend = 0.055). The positive association
between trans fat intake and ischemic stroke was consistent among Caucasians only (HR
1.54, 95% CI 1.17, 2.03, P for trend = 0.02). In recent years, the definition of TIA has
evolved so that some patients diagnosed with TIA may actually have ischemic stroke. When
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we included participants with TIAs as ischemic stroke cases, the association was attenuated,
but remained positive (HR 1.11, 95% CI 0.92, 1.34, P for trend = 0.31).
Among the 1,049 incident cases of ischemic stroke, there were 101 atherotherombotic, 234
cardioembolic, and 269 lacunar infarctions; 445 were of unspecified etiology, had multiple
causes, or had a negative or incomplete evaluation and were not included in subtype
analysis. After adjustment for clinical, lifestyle, and dietary factors, increased trans fat
intake was associated with higher risk of lacunar infarction (Table 3). However, no
statistically significant associations were found between other types of fat intake and
subtypes of ischemic stroke. We found no significant associations with ischemic stroke in
our examination of food groups rich in fat or cholesterol after adjustment for possible
confounders (Table 4).
DISCUSSION
In the largest cohort study of strokes among postmenopausal women, we observed a positive
association between trans fat intake and incidence of ischemic stroke that persisted after
adjustment for major lifestyle, cardiovascular, and dietary factors. This association was
substantially attenuated among women using aspirin. The WHI FFQ dietary assessment,
designed specifically to measure fat intake, was repeated and validated. In addition, stroke
was ascertained rigorously in the WHI.
Two prospective studies of male and female healthcare professionals, the Health
Professionals Follow-up Study and the Nurses’ Health Study with 455 and 385 cases of
ischemic stroke, respectively, did not find significant associations for total fat, cholesterol,
or specific types of fat, including trans fat, and ischemic stroke after adjustment for potential
confounders and major lifestyle variables.2, 3
Our unique study base of older women may have contributed to our ability to detect the
association between trans fat intake and ischemic stroke among non-users of aspirin. In a
trial of platelet reactivity, women’s platelets were more reactive than men’s to most agonists
and platelet response after taking 81-mg/d aspirin decreased the same or more in women
than men.14 A sex-specific meta-analysis of randomized trials found that aspirin therapy
(75–500 mg/d) reduced risk of cardiovascular disease by 12% mainly due to a 24%
reduction in risk of ischemic stroke among women but not men.7 Increased platelet response
to an agonist and inhibition after aspirin intake may at least in part explain the attenuated
association between trans fat intake and ischemic stroke among aspirin users in this cohort.
Platelet aggregability increases with advancing age, possibly more so among women than
men.15 A case-control study of serum saturated fatty acids and ischemic stroke reported a
positive association among middle-aged men, but not younger men, suggesting that these
associations may vary by age.16 The older age range of women in WHI-OS could explain
why the association between trans fat intake and ischemic stroke was found in the older, but
not the younger Nurses’ Health Study, cohort.
In addition to its function as an anti-platelet, aspirin reduces inflammation by blocking
prostaglandin synthesis at higher doses. While less than 1% of WHI-OS aspirin users
reported taking high-dose (≥4 g/d) aspirin, there is evidence that lower doses of aspirin are
also anti-inflammatory. The Physicians’ Health Study reported that the risk reduction of
myocardial infarction decreased in a linear fashion across quintiles of CRP in the 325-mg
aspirin treatment group, suggesting that low-dose aspirin may have anti-inflammatory
effects.17 Also, aspirin use has been linked with attenuated associations in studies of trans
fat intake and inflammatory diseases, such as colorectal and prostate cancer.18, 19 Ischemic
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stroke prevention guidelines recommend that aspirin be used among women with sufficient
risk of stroke to outweigh possible harm due to bleeding.20
Women with higher trans fat intake had elevated incidence of lacunar and cardioembolic,
but not atherothrombotic infarction, the subtype of ischemic stroke that has been associated
with elevated total cholesterol and decreased HDL-C.21 In addition, we found no statistically
significant associations between other types of fat and incidence of ischemic stroke,
highlighting the uncertainty that dietary fat intake acts through dyslipidemia to cause
cerebral infarction.4 While dyslipidemia is an established risk factor for CHD, accumulated
evidence on the association between cholesterol and ischemic stroke revealed null or weak
associations. A meta-analysis of randomized trials of nonstatin lipid lowering did not
translate to decreased risk of stroke, even though the trials were successful in lowering mean
cholesterol level in the treatment versus placebo groups by 6%-23%22. In addition, a meta-
analysis of 450,000 individuals from 45 prospective cohorts reported that there was no
association between blood cholesterol and stroke after standardizing by age.23 However,
recent trials of cholesterol-lowering using statin drugs suggested that incidence of ischemic
stroke may be reduced, but these effects are likely independent of reduction in serum total
cholesterol.24, 25 Statins are thought to have diverse beneficial effects on vascular risk
factors that extend beyond its cholesterol-lowering properties.26 Despite the clear benefit of
statin therapy in high-risk individuals, there is limited evidence showing the benefit of statin
therapy among low-risk individuals for the primary prevention of cardiovascular disease.27
In our study, statistical power for comparisons by statin use was lower than for aspirin use.
It could have limited our capability of examining statin’s effect modification.
To our knowledge, only one prospective study has reported significant associations between
types of fat and stroke subtypes.28 Iso et al. reported that serum saturated fatty acids were
positively associated with incidence of ischemic stroke, while serum linoleic acid was
associated with decreased incidence of ischemic stroke. These associations were largely
driven by lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes.
Investigators did not examine serum trans fat and acknowledged the uncertainty of the
associations for other ischemic stroke subtypes. Further exploration is needed on the
association between types of fat and ischemic stroke subtypes.
The WHI FFQ, which was designed to emphasize measurement of fatty acid intakes because
it was a key measure in the WHI Dietary Modification Trial, is a strength of the present
study. However, the WHI FFQ is subject to the same challenges as other self-reported
dietary assessment methods commonly used in large-scale prospective cohort studies. The
WHI FFQ performed similar to or better than others in similar populations.8 We reduced
error in the dietary assessment and accounted for possible changes in diet during follow-up
by using the cumulative average of two dietary measurements. The results are unlikely to be
due to confounding, as the results remained consistent through several sensitivity analyses
and we considered numerous dietary and lifestyle variables. However, in any observational
study the possibility of confounding by unknown factors cannot be completely excluded.
The WHI-OS includes by far the largest number of ischemic strokes studied to date with
respect to dietary fat intake with a long follow-up of an average of 8 years. Importantly, the
ischemic stroke and subtype classifications in the WHI were centrally adjudicated, reducing
the likelihood of misclassification. One concern of the study is the statistical power for the
atherothrombotic infarction, the least prevalent ischemic stroke subtype in the US. However,
the number of atherothrombotic infarction cases in this study exceeds the number of total
ischemic stroke cases in many previous studies.
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In summary, a significant and positive association between trans fat intake and ischemic
stroke was present among non-users of aspirin and absent among users of aspirin. Our
results highlight the importance of limiting the amount of dietary trans fat intake and using
aspirin for primary ischemic stroke prevention among women, specifically postmenopausal
women who have elevated risk of ischemic stroke.
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Adjusted hazard ratios (HR) and 95% confidence intervals (CI) for ischemic stroke by
quintiles (Q) of trans fat intake among non-aspirin users (A) and aspirin users (B). The P-
value for interaction comparing the hazard ratios with interaction present vs. hazard ratios
with interaction absent = 0.02. The HRs were adjusted for covariates listed in Table 2.
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